Skip to main content

Table 1 Characteristics of patients

From: Limited cross-border infections in patients newly diagnosed with HIV in Europe

Characteristics

Categories

Total patients

Patients

 

4260

Continent of Origin, no. (%)

Western Europe

2361 (55.4)

Eastern Europe & Central Asia

915 (21.5)

Sub-Saharan Africa

467 (11.0)

Other

517 (12.1)

Baseline values

HIV-RNA load, mean (IQR), log copies/ml

4.8 (4.3-5.3)

CD4 cell count, median (IQR), cells/mm3

354 (181–540)

Age, mean years (IQR)

36.3 (29–42)

Gender, no. (%)

male

3361 (78.9)

Risk group, no. (%)

Men having Sex with Men (MSM)

2061 (48.4)

Heterosexual contact

1477 (34.7)

Injection drug use

347 (8.1)

Other

39 (0.9)

unknown

336 (7.9)

CDC stage, no. (%)

A and B

3537 (83.0)

C

516 (12.1)

Subtype, no. (%)

B

2820 (66.2)

A

477 (11.2)

C

291 (6.8)

02_AG

197 (4.6)

G

137 (3.2)

F

92 (2.2)

others

167 (3.9)

unassigned

79 (1.9)

non-B

1361 (31.9)

Duration of infection, no. (%)

<1 year

1228 (28.8)

1-2 years

141 (3.3)

Unknown duration

2891 (67.9)

TDRM, no. (%)

present

380 (8.9)

  1. NOTE. Data are no. (%) of patients, unless otherwise indicated. Characteristics describe patients from whom a baseline HIV-1 genotypic analysis was available. CDC Centers for disease control and prevention; IQR Interquartile ranges; MSM Men who have sex with men; TDRM Transmitted drug resistance mutations.